Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,967.38
(
1.18%
)
US TECH 100
25,156.80
(
1.87%
)
Dow Jones
48,535.99
(
0.66%
)
Brent Oil
92.34
(
-3.27%
)
Bitcoin
73,984.20
(
-0.29%
)
News Focus
News Focus
Post# of 257406
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122868
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: None

Monday, 01/10/2022 11:30:15 AM

Monday, January 10, 2022 11:30:15 AM

Post# of 257406
BMY issues 2022 non-GAAP EPS guidance of $7.65-7.95—starts $15M share-repurchase program with $5M ASR in 1Q22:

https://finance.yahoo.com/news/bristol-myers-squibb-highlight-long-114500205.html

Today, the Company also announced that it plans to execute an accelerated share repurchase (ASR) agreement during the first quarter of 2022 to repurchase up to $5 billion of Bristol Myers Squibb common stock. The ASR is part of the Company’s previously disclosed multi-year $15 billion share repurchase authorization.

JPM CC slides:
https://www.sec.gov/Archives/edgar/data/0000014272/000114036122001018/brhc10032672_ex99-1.htm

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today